The Role of Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists in the Prevention and Treatment of Diabetic Kidney Disease: Insights from the AMPLITUDE-O Trial. Issue 6 (June 2022)

Record Type:: Journal Article
Title:: The Role of Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists in the Prevention and Treatment of Diabetic Kidney Disease: Insights from the AMPLITUDE-O Trial. Issue 6 (June 2022)
Main Title:: The Role of Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists in the Prevention and Treatment of Diabetic Kidney Disease
Authors:: Tommerdahl, Kalie L.
Kendrick, Jessica
Bjornstad, Petter
Abstract:
Is Part Of:: Clinical journal of the American Society of Nephrology. Volume 17:Issue 6(2022)
Journal:: Clinical journal of the American Society of Nephrology
Issue:: Volume 17:Issue 6(2022)
Issue Display:: Volume 17, Issue 6 (2022)
Year:: 2022
Volume:: 17
Issue:: 6
Issue Sort Value:: 2022-0017-0006-0000
Page Start:: 905
Page End:: 907
Publication Date:: 2022-06
Subjects:: diabetic nephropathy -- albuminuria -- clinical trial -- cardiovascular disease -- diabetes mellitus
DOI:: 10.2215/CJN.00020122 ↗
Languages:: English
ISSNs:: 1555-9041
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library HMNTS - ELD Digital store
Ingest File:: 26449.xml